Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
BULK IBUPROFEN DELIVERY ORDER FOR THE THE PHARM REPACKAGING PROGRAM FOR THE MONTH OF SEPTEMBER OCTOBER 2022 WITH EXELAN PHARMACEUTICALS. is a federal award for Nac Pharmaceuticals (36E797) held by Exelan Pharmaceuticals Inc. Estimated value $242K ($242K obligated). Current period of performance ends Sep 30, 2022. Place of performance: BOCA RATON FL.
BULK IBUPROFEN DELIVERY ORDER FOR THE THE PHARM REPACKAGING PROGRAM FOR THE MONTH OF SEPTEMBER OCTOBER 2022 WITH EXELAN PHARMACEUTICALS.
Recompete timing
PublicCurrent PoP ended Sep 30, 2022 (1421 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordExelan Pharmaceuticals Inc — $184.3M obligated across 125 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36E79722N0031?
36E79722N0031 (BULK ibuprofen delivery ORDER for the) is a Nac Pharmaceuticals (36E797) award with a potential value of $242K, currently held by Exelan Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36E797-22-N-0031?
36E797-22-N-0031 is the dashed form of PIID 36E79722N0031 (BULK ibuprofen delivery ORDER for the), held by Exelan Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36E79722N0031?
Nac Pharmaceuticals (36E797) awarded 36E79722N0031 to Exelan Pharmaceuticals Inc (potential $242K).
Who is the incumbent on 36E79722N0031?
Exelan Pharmaceuticals Inc is the incumbent with $184.3M across 125 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2022.
When does Exelan Pharmaceuticals Inc’s 36E79722N0031 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.